Authors' objectives: We identified and summarised evidence addressing the following review question: what is the clinical and cost effectiveness of stereotactic ablative radiotherapy (SABR) for primary kidney cancer compared to standard care?
Stereotactic ablative radiotherapy (SABR); Stereotactic body radiotherapy (SBRT); Kidney cancer; Renal cancer; Renal carcinoma; Renal cell carcinoma (RCC)
10.5
